Einführung
R-(+)-Etomoxir is a carnitine palmitoyltransferase I (CPT1) inhibitor which is required for the oxidation of long chain acyl CoA esters. It inhibits ß-oxidation in mitochondria and shown to inhibit biosynthesis of cardiolipin from exogenous fatty acid in H9c2 cells. Potential antidiabetic drug.
